+34 976 765500. Ext. 5370/5375 epichron.iacs@aragon.es

VAC4EU active safety surveillance study of the BNT162b2 COVID-19 vaccine in four European countries: study design and first results

por | Oct 3, 2022 | Comunicaciones

Daniel Weibel, et al. 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 2022 Enlace